How do you decide between administering or deferring upstream P2Y12 inhibitor treatment until patient is in the lab for NSTEMI or STEMI cases with unknown coronary anatomy?
Community PollStarted
When treating NSTEMI or STEMI patients with unknown coronary anatomy, what is your primary approach to administering upstream P2Y12 inhibitor treatment?
80 physicians have voted
Join Mednetto vote and see how they answered.
2 Answers
Mednet MemberInvited Expert
Cardiology · University Of California San Francisco Medical Center At Parnassus
Answered on · Updated on
Unless you are using clopidogrel there’s no need to consider upstream use in STEMI. In NSTEMI, you can use heparin/lovenox or a P2Y12 no need for both.
If you don’t know the anatomy you’re gambling to give upstream P2Y12.
In ACS administration of a P2Y12 inhibitor before assessment of coronary anato...
Join for free or sign in to see the full answer
Mednet Member
Cardiology · Kaiser Permanente Panorama City Medical Center
Answered on
Agreed.
Join for free or sign in to see the full answer